INSMED INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
INSMED INC (INSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 315.99 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-02-19
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-12-31 was 305.58K shares, a 1009.11% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-09-30 was 102.93K shares, a 156.64% increase year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-06-30 was 26.86K shares, a 64.99% decline year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-03-31 was 53.07K shares, a 80.33% decline year-over-year.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 315.99K shares, a 57.05% decline from fiscal 2024.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 735.73K shares, a 7.07% decline from fiscal 2023.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 791.67K shares, a 22.88% decline from fiscal 2022.
- INSMED INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 1.03M shares, a 4.90% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2025-12-31 | 315.99K shares 10-K · filed 2026-02-19 | |||
| 2024-12-31 | 735.73K shares 10-K · filed 2025-02-20 | |||
| 2023-12-31 | 791.67K shares 10-K · filed 2025-02-20 | |||
| 2022-12-31 | 1.03M shares 10-K · filed 2025-02-20 | |||
| 2021-12-31 | 978.62K shares 10-K · filed 2024-02-22 | |||
| 2020-12-31 | 541.68K shares 10-K · filed 2023-02-23 | |||
| 2019-12-31 | 909.71K shares 10-K · filed 2022-02-17 | |||
| 2018-12-31 | 305.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 408.51K shares derived: sum of 2 quarters · filed 2021-02-25 | 435.37K shares derived: sum of 3 quarters · filed 2021-02-25 | 488.44K shares 10-K · filed 2021-02-25 |
| 2018-09-30 | 102.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 129.79K shares derived: sum of 2 quarters · filed 2018-10-30 | 182.86K shares 10-Q · filed 2018-10-30 | 210.41K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 26.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 79.93K shares 10-Q · filed 2018-08-02 | 107.48K shares derived: sum of 3 quarters · filed 2020-02-25 | 147.59K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 53.07K shares 10-Q · filed 2018-05-02 | 80.62K shares derived: sum of 2 quarters · filed 2020-02-25 | 120.73K shares derived: sum of 3 quarters · filed 2020-02-25 | 197.45K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 27.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 67.66K shares derived: sum of 2 quarters · filed 2020-02-25 | 144.38K shares derived: sum of 3 quarters · filed 2020-02-25 | 414.22K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 40.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 116.83K shares derived: sum of 2 quarters · filed 2017-11-02 | 386.67K shares 10-Q · filed 2017-11-02 | 560.67K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | 76.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 346.56K shares 10-Q · filed 2017-08-03 | 520.56K shares derived: sum of 3 quarters · filed 2019-02-22 | 811.69K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | 269.84K shares 10-Q · filed 2017-05-03 | 443.83K shares derived: sum of 2 quarters · filed 2019-02-22 | 734.96K shares derived: sum of 3 quarters · filed 2019-02-22 | 771.26K shares derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | 174.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 465.13K shares derived: sum of 2 quarters · filed 2019-02-22 | 501.43K shares derived: sum of 3 quarters · filed 2019-02-22 | 527.35K shares 10-K · filed 2019-02-22 |
| 2016-09-30 | 291.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 327.43K shares derived: sum of 2 quarters · filed 2016-11-03 | 353.35K shares 10-Q · filed 2016-11-03 | 472.92K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | 36.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 62.23K shares 10-Q · filed 2016-08-04 | 181.79K shares derived: sum of 3 quarters · filed 2018-02-23 | 311.70K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | 25.93K shares 10-Q · filed 2016-05-05 | 145.49K shares derived: sum of 2 quarters · filed 2018-02-23 | 275.40K shares derived: sum of 3 quarters · filed 2018-02-23 | 554.27K shares derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | 119.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | 249.47K shares derived: sum of 2 quarters · filed 2018-02-23 | 528.34K shares derived: sum of 3 quarters · filed 2018-02-23 | 548.09K shares 10-K · filed 2018-02-23 |
| 2015-09-30 | 129.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | 408.78K shares derived: sum of 2 quarters · filed 2015-11-06 | 428.53K shares 10-Q · filed 2015-11-06 | 581.06K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | 278.87K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | 298.62K shares 10-Q · filed 2015-08-06 | 451.15K shares derived: sum of 3 quarters · filed 2017-02-23 | 816.81K shares derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | 19.75K shares 10-Q · filed 2015-05-07 | 172.28K shares derived: sum of 2 quarters · filed 2017-02-23 | 537.94K shares derived: sum of 3 quarters · filed 2017-02-23 | |
| 2014-12-31 | 152.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 518.19K shares derived: sum of 2 quarters · filed 2017-02-23 | 550.28K shares 10-K · filed 2017-02-23 | |
| 2014-09-30 | 365.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 397.75K shares 10-Q · filed 2014-11-06 | ||
| 2014-06-30 | 32.10K shares 10-Q · filed 2014-08-06 | |||
| 2013-12-31 | 117.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 124.35K shares derived: sum of 2 quarters · filed 2016-02-25 | 131.60K shares derived: sum of 3 quarters · filed 2016-02-25 | 136.60K shares 10-K · filed 2016-02-25 |
| 2013-09-30 | 6.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | 14.10K shares derived: sum of 2 quarters · filed 2013-11-05 | 19.10K shares 10-Q · filed 2013-11-05 | |
| 2013-06-30 | 7.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 12.25K shares 10-Q · filed 2013-08-06 | ||
| 2013-03-31 | 5.00K shares 10-Q · filed 2013-05-07 | |||
| 2012-12-31 | 160.05K shares 10-K · filed 2015-02-27 | |||
| 2011-12-31 | 83.32K shares 10-K · filed 2014-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |